rs757711844
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_032447.5(FBN3):c.8428T>C(p.Ter2810Glnext*?) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,568,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032447.5 stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN3 | ENST00000600128.6 | c.8428T>C | p.Ter2810Glnext*? | stop_lost | Exon 64 of 64 | 1 | NM_032447.5 | ENSP00000470498.1 | ||
FBN3 | ENST00000270509.6 | c.8428T>C | p.Ter2810Glnext*? | stop_lost | Exon 63 of 63 | 1 | ENSP00000270509.2 | |||
FBN3 | ENST00000601739.5 | c.8428T>C | p.Ter2810Glnext*? | stop_lost | Exon 64 of 64 | 1 | ENSP00000472324.1 | |||
FBN3 | ENST00000651877.1 | c.8554T>C | p.Ter2852Glnext*? | stop_lost | Exon 64 of 64 | ENSP00000498507.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000227 AC: 5AN: 220620Hom.: 0 AF XY: 0.0000167 AC XY: 2AN XY: 119410
GnomAD4 exome AF: 0.0000191 AC: 27AN: 1416360Hom.: 0 Cov.: 30 AF XY: 0.0000157 AC XY: 11AN XY: 699414
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change disrupts the translational stop signal of the FBN3 mRNA. It is expected to extend the length of the FBN3 protein by 22 additional amino acid residues. This variant is present in population databases (rs757711844, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FBN3-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at